Bispebjerg Hospital, Neurologisk afdeling
Copenhagen, Region H, 2400, Denmark
NCT Number: NCT01472224
This study investigates the ability of ultrasound to measure the volume of a brain hemorrhage in the acute phase after hospital admission.
It is known that approximately 30% of patients admitted with a brain hemorrhage will suffer from enlargement of the hematoma within the first hours after admission.
In this study the investigators measure the volume of the hematoma every 30 minutes up to 6 hours after admission and every 2 hours between 6-12 hours.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Copenhagen, Region H, 2400, Denmark
This study investigates the use of transcranial ultrasound (TCU) for the surveillance of patients with intracerebral hemorrhages. Using transcranial ultrasound makes it possible to visualize and follow the bleeding progression through 3 points of the scull where the bone is thin enough to allow the penetration of sound waves. This can be done at bedside. Today the investigators do not know for sure if clinical parameters determine a haematoma expansion. TCU will allow us to follow the haematoma progression serially in the acute phase and relate the haematoma expansion to parameters like blood pressure, neurological status (NIHSS-score) and radiological signs of ongoing bleeding (spot signs) on CT-angiogram (CTA).
Hypothesis:
Aim of study:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bispebjerg Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03209258
Anticoagulant-induced Bleeding, Brain Diseases
Chengdu, Sichuan, China
View Trial DetailsNCT03000283
Brain Diseases, Brain Edema
Saint Paul, Minnesota, United States
View Trial DetailsNCT03148340
Brain Diseases, Brain Infarction
Jacksonville, Florida, United States
View Trial DetailsNCT03177161
Brain Diseases, Brain Infarction
Ystrad Mynach, Caerphilly, United Kingdom
View Trial Details